XML 14 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Sep. 30, 2018 $ 9,657 $ 6,052,161 $ (10,457,710) $ (4,395,892)
Balance, shares at Sep. 30, 2018 9,656,505      
Issuance of common stock under private placement $ 330 601,319 601,649
Issuance of common stock under private placements, shares 330,000      
Issuance of warrants under private placements 223,351 223,351
Issuance costs related to private placements (149,316) (149,316)
Issuance of common stock for consulting services $ 50 114,950 115,000
Issuance of common stock for consulting services, shares 50,000      
Net loss (1,352,824) (1,352,824)
Balance at Dec. 31, 2018 $ 10,037 6,842,465 (11,810,534) (4,958,032)
Balance, shares at Dec. 31, 2018 10,036,505      
Balance at Sep. 30, 2018 $ 9,657 6,052,161 (10,457,710) (4,395,892)
Balance, shares at Sep. 30, 2018 9,656,505      
Balance at Mar. 31, 2019 $ 12,945 14,454,110 (14,022,424) 444,631
Balance, shares at Mar. 31, 2019 12,944,514      
Balance at Dec. 31, 2018 $ 10,037 6,842,465 (11,810,534) (4,958,032)
Balance, shares at Dec. 31, 2018 10,036,505      
Issuance of common stock under private placement $ 1,744 3,164,640 3,166,384
Issuance of common stock under private placements, shares 1,743,979      
Issuance of warrants under private placements 1,193,564 1,193,564
Issuance costs related to private placements (698,777) (698,777)
Issuance of common stock upon conversion of convertible promissory notes $ 839 1,920,881 1,921,720
Issuance of common stock upon conversion of convertible promissory notes, shares 839,179      
Issuance of warrants and reclassification of warrant liability upon conversion of convertible promissory notes 1,921,720 1,921,720
Issuance of warrants and reclassification of warrant liability upon conversion of convertible promissory notes, shares      
Share-based compensation - employee 30,085 30,085
Share-based compensation - non-employee 16,569 16,569
Exercise of stock options $ 94 3,179 3,273
Exercise of stock options, shares 93,555      
Exercise of warrants $ 231 416,102 (14,022,424) 416,333
Exercise of warrants, shares 231,296      
Net loss     (2,211,890) (2,211,890)
Balance at Mar. 31, 2019 $ 12,945 14,454,110 (14,022,424) 444,631
Balance, shares at Mar. 31, 2019 12,944,514      
Balance at Sep. 30, 2019 $ 13,494 15,987,799 (17,238,871) (1,237,578)
Balance, shares at Sep. 30, 2019 13,493,705      
Issuance of common stock under securities purchase agreement $ 142 254,858 255,000
Issuance of common stock under securities purchase agreement, shares 141,666      
Issuance of warrants in connection with convertible notes offering 419,635 419,635
Stock-based compensation 463,084 463,084
Issuance of common stock for consulting services $ 90 124,503 124,593
Issuance of common stock for consulting services, shares 90,000      
Issuance of common stock upon vesting of restricted stock units $ 11 (11)
Issuance of common stock upon vesting of restricted stock units, shares 10,503      
Net loss (4,637,066) (4,637,066)
Balance at Dec. 31, 2019 $ 13,737 17,249,868 (21,875,937) (4,612,332)
Balance, shares at Dec. 31, 2019 13,735,874      
Stock-based compensation 88,806 88,806
Issuance of common stock upon conversion of convertible promissory notes $ 61 239,461 239,522
Issuance of common stock upon conversion of convertible promissory notes, shares 60,847      
Exercise of stock options $ 42 1,446 1,488
Exercise of stock options, shares 42,525      
Issuance of common stock for consulting services $ 61 153,520 153,581
Issuance of common stock for consulting services, shares 61,000      
Issuance of common stock upon vesting of restricted stock units $ 122 289,272 289,394
Issuance of common stock upon vesting of restricted stock units, shares 122,177      
Net loss (1,345,642) (1,345,642)
Balance at Mar. 31, 2020 $ 14,023 $ 18,022,373 $ (23,221,579) $ (5,185,183)
Balance, shares at Mar. 31, 2020 14,022,423